Libutti is the director of the Rutgers Cancer Institute of New Jersey and vice chancellor for Cancer Programs at Rutgers Biomedical and Health Sciences. The institute broke ground last year on a new cancer pavilion in New Brunswick that’ll fill oncological treatment needs all in one hub: laboratory services, an outpatient clinic, infusion/chemotherapy suite, radiation oncology, imaging, and international radiology. The institute broke ground last summer and construction is under way.
Meanwhile, the institute launched the state’s first home infusion pilot program in November alongside Horizon Blue Cross Blue Shield of New Jersey.
“Offering the opportunity to transition eligible patients from infusion centers to home-based infusion of chemotherapy for the first time in New Jersey speaks to our mission of providing the most compassionate world-class cancer care and is what we strive to do with this pilot program,” he said at the time.
And he explained, in the pages of NJBIZ, how patients would benefit. “We know that a cancer diagnosis does not only impact the patient, but it also often affects the patient’s entire support network. Having the best possible therapies close to home makes the treatment experience—which can involve multiple modalities and be time intensive—easier on both the patient and his or her support team,” Libutti wrote.
“By providing inpatient care in conjunction with world-class treatment from top clinical professionals and unique patient amenities all in one footprint, we are enhancing the level of care for the patients we serve in New Jersey and beyond.”